AI
USNA icon

Analytic Investors’s Usana Health Sciences USNA Stock Holding History

Analytic Investors’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,208
Closed -$684K – 679
2015
Q3 		$684K Buy
+10,208
New +$722K 0.01% 414

Other funds holding USNA

ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Analytic Investors's USNA Position: Q4 2015 in Review

Analytic Investors sold out of Usana Health Sciences (USNA) in Q4 2015, closing a stake of 10,208 shares — an estimated $684K sold.

Analytic Investors first reported a position in USNA in Q3 2015 and held it in 1 quarter. The position peaked at $684K in Q3 2015. 161 funds tracked by Wall St. Rank hold USNA as of Q4 2015.

  • Analytic Investors reported no remaining Usana Health Sciences position as of Q4 2015 after selling out during the quarter.
  • Analytic Investors sold 10,208 Usana Health Sciences shares in Q4 2015, an estimated $684K.
  • Analytic Investors first reported a position in Usana Health Sciences in Q3 2015 and held it in 1 quarter.
  • Analytic Investors's Usana Health Sciences position peaked at $684K in Q3 2015.
  • 161 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2015.

Based on Analytic Investors's 13F filing for Q4 2015, filed 12 Feb 2016.